Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.540
-0.026 (-1.69%)
Aug 25, 2025, 4:00 PM - Market closed

Cocrystal Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
162118166393
Upgrade
Market Cap Growth
-36.05%17.29%10.34%-74.94%-32.06%435.38%
Upgrade
Enterprise Value
139-12-26262
Upgrade
Last Close Price
1.542.021.721.957.8016.32
Upgrade
PS Ratio
-----46.30
Upgrade
PB Ratio
2.942.160.660.400.821.78
Upgrade
P/TBV Ratio
2.962.160.660.401.082.79
Upgrade
EV/Sales Ratio
-----30.84
Upgrade
Debt / Equity Ratio
0.310.190.070.010.010.01
Upgrade
Asset Turnover
-----0.05
Upgrade
Quick Ratio
3.504.568.3531.1438.0024.72
Upgrade
Current Ratio
3.704.778.9233.0438.4025.05
Upgrade
Return on Equity (ROE)
-110.56%-97.50%-54.54%-66.32%-21.81%-24.67%
Upgrade
Return on Assets (ROA)
-52.87%-49.98%-36.68%-18.86%-13.30%-14.48%
Upgrade
Return on Capital (ROIC)
-60.78%-56.48%-38.84%-19.22%-13.55%-15.05%
Upgrade
Earnings Yield
-79.51%-85.17%-102.64%-244.58%-22.39%-10.35%
Upgrade
FCF Yield
-84.67%-80.25%-84.38%-135.46%-20.16%-10.80%
Upgrade
Buyback Yield / Dilution
0.09%-5.42%-18.52%-10.58%-60.04%-73.32%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q